Cover Image

The pathogenic role of calcitonin gene‐related peptide and predictors of new‐onset migraine and long‐term outcomes after transcatheter atrial septal defect closure

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Tzu‐Hsuan Su, Jou‐Kou Wang, Ping‐Hung Kuo, Shu‐Hui Chang, Lih‐Chu Chiou, Wang‐Tso Lee, Pi‐Chuan Fan
Format:	Artículo Open Access
Published:	Wiley 2024
Subjects:	Headache: The Journal of Head and Face Pain
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Genetic migraine disorders and the response to calcitonin gene‐related peptide antagonist treatment
by: Andrea M. Kuczynski, et al.
Published: (2025)

Evaluating dual calcitonin gene‐related peptide antagonists for chronic migraine prevention
by: Kara S. Graves, et al.
Published: (2026)

Patient reported outcomes and the real‐world use of calcitonin gene–related peptide medications in migraine
by: Samuel K. Peasah, et al.
Published: (2024)

Persistence, effectiveness, and tolerability of anti‐calcitonin gene–related peptide monoclonal antibodies in patients with chronic migraine
by: Anna de Dios, et al.
Published: (2024)

Patient satisfaction with calcitonin gene‐related peptide monoclonal antibodies in migraine: A multicenter prospective cohort study
by: Alba López‐Bravo, et al.
Published: (2025)

Treatment of abdominal migraine in an 8‐year‐old child with calcitonin gene‐related peptide receptor antagonist: A case report
by: Yunzhu Tang, et al.
Published: (2025)

Letter to the Editor regarding “Persistence, effectiveness, and tolerability of anti‐calcitonin gene‐related peptide monoclonal antibodies in patients with chronic migraine”
by: Joaquín Borrás‐Blasco, et al.
Published: (2025)

Differences in circulating alpha‐calcitonin gene–related peptide levels in inflammatory bowel disease and its relation to migraine comorbidity: A cross‐sectional study
by: Marta Pascual‐Mato, et al.
Published: (2024)

Nonspecific oral medications versus anti–calcitonin gene‐related peptide monoclonal antibodies for migraine: A systematic review and meta‐analysis of randomized controlled trials
by: Jennifer Robblee, et al.
Published: (2024)

Migraine, idiopathic intracranial hypertension, and calcitonin gene‐related peptide antibodies
by: Irina Krikova, et al.
Published: (2024)

Development and pharmacological characterization of novel multi‐ calcitonin gene‐related peptide and pituitary adenylate cyclase‐activating peptide receptor antagonists
by: Zoe Tasma, et al.
Published: (2025)

Amplifying and ameliorating light avoidance in mice with photoreceptor targeting and calcitonin gene‐related peptide sensitization
by: Eric A. Kaiser, et al.
Published: (2025)

Potential drug interaction between calcitonin gene‐related peptide antagonists and neonatal Fc receptor inhibitors
by: Alex Harlan, et al.
Published: (2025)

Arterial hypertension: A safety risk of calcitonin gene‐related peptide ligand and receptor blocker class
by: David Croteau, et al.
Published: (2026)

Blood serum levels of PACAP and migraine onset: A systematic review and meta‐analysis of observational studies
by: Guoliang Zhu, et al.
Published: (2024)

Comment on “Plasma calcitonin gene‐related peptide and nerve growth factor as headache and pain biomarkers in recently deployed soldiers with and without a recent concussion”
by: Gabriel Gárate, et al.
Published: (2024)

Author Response to Comment on “Plasma calcitonin gene‐related peptide and nerve growth factor as headache and pain biomarkers in recently deployed soldiers with and without a recent concussion”
by: Ann I. Scher, et al.
Published: (2024)

Engagement and predictors of use of a smartphone app for migraine self‐management: A secondary analysis of the EMMA trial
by: Stefanie Lysk, et al.
Published: (2025)

Mapping the migraine: Intracranial recording of cortical spreading depression in migraine with aura
by: Graham A. McLeod, et al.
Published: (2025)

Calcitonin gene‐related peptide‐targeting therapies are a first‐line option for the prevention of migraine: An American Headache Society position statement update
by: Andrew C. Charles, et al.
Published: (2024)

Effect of erenumab on the reversion from chronic migraine to episodic migraine in an Asian population: A post hoc analysis of the DRAGON study
by: Shuu‐Jiun Wang, et al.
Published: (2024)

Higher artificial intelligence‐ ECG atrial fibrillation prediction model output and estimated physiologic aging predict higher risk of adverse vascular events in patients with migraine
by: Ping‐Hao Yang, et al.
Published: (2026)

The impacts of migraine on functioning: Results from two qualitative studies of people living with migraine
by: Rikki Mangrum, et al.
Published: (2024)

The effect of different exercise types on migraine frequency in individuals with migraine: A pilot study
by: Yunus Emre Meydanal, et al.
Published: (2025)

Advancing toward precision migraine treatment: Predicting responses to preventive medications with machine learning models based on patient and migraine features
by: Chia‐Chun Chiang, et al.
Published: (2024)

The role of stress in the comorbidity of migraine and other chronic primary pain
by: Shi‐Jie Zhao, et al.
Published: (2025)

Investigating the causal and genetic relationship between migraine and Parkinson's disease
by: Ming‐Gang Deng, et al.
Published: (2024)

Evaluating associations of migraine‐related vertigo
by: Nazia Karsan, et al.
Published: (2025)

Afterimage duration differs for migraine with or without aura
by: Florian Rimmele, et al.
Published: (2025)

Mechanisms for mindfulness in migraine: Does catastrophizing matter?
by: Rebecca Erwin Wells, et al.
Published: (2024)

Useful considerations for treating migraine in patients with autism
by: Sinifunanya E. Nwaobi
Published: (2026)

Lifestyle triggers of migraine: Sleep restriction and caffeine lower the threshold for migraine‐like responses in rats in a sex‐specific manner
by: Gabriel Camargo de Oliveira, et al.
Published: (2026)

No association between migraine and HLA alleles in a cohort of 13,210 individuals with migraine from the Danish Blood Donor Study
by: Inga Zalia Tummoszeit, et al.
Published: (2024)

Counting the cost: How migraine shapes lives and economies
by: Risako Shirane, et al.
Published: (2025)

Cardiovascular risk and triptan usage among patients with migraine
by: Ido Peles, et al.
Published: (2025)

Depression and anxiety are not associated with migraine outcomes in children and adolescents
by: Amy A. Gelfand
Published: (2024)

Cognitive and emotional mechanisms underlying migraine quality of life
by: Shiri Shinan‐Altman, et al.
Published: (2026)

Integrating gepants into clinical practice for the acute treatment of migraine
by: Richard B. Lipton, et al.
Published: (2026)

Plain Language Summary Publication: Investigating the causal and genetic relationship between migraine and Parkinson’s disease
by: Ming‐Gang Deng, et al.
Published: (2025)

A retrospective analysis of the use of candesartan for migraine prevention in adolescents
by: Irene Patniyot, et al.
Published: (2024)